{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-011292","form_type":"8-K","ticker":"IMDX","cik":"0001642380","company_name":"Insight Molecular Diagnostics Inc.","filed_at":"2023-04-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.798279+00:00","generated_at":"2026-06-17T05:11:06.683521+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Oncocyte raises ~$13.5M in offering of 45.5M shares at $0.302-$0.354","bullets":["Net proceeds of ~$13.5M after $250K advisory fee and other expenses.","~$1.1M used to redeem Series A Preferred stock; remainder for working capital and product commercialization.","Broadwood Partners (largest shareholder) and board members participated as insiders at $0.35440 per share.","Offering conducted as takedown from existing S-3 shelf registration statement declared effective June 2021.","Company intends to use funds to support VitaGraft, DetermaIO, and DetermaCNI development."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-011292","json":"https://secwatch.observer/filing/0001493152-23-011292.json","markdown":"https://secwatch.observer/filing/0001493152-23-011292.md","text":"https://secwatch.observer/filing/0001493152-23-011292.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1642380/000149315223011292/0001493152-23-011292-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1642380/000149315223011292/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T05:11:06.683521+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}